熱點掃描 | 科技股持續拉昇,藥品、生物技術板塊走強
uSMART盈立智投3月30日消息,截至10:40,恆生指數震盪上行,漲0.80%,報28565.44,成交額517.12億。國企指數漲0.87%。恆生科技指數持續拉昇,漲2.68%。港股通淨流入13.94億。
恆生科技指數反彈,截至10:15,聯想集團大漲超7%,消息面上,聯想控股斥2.25億增持聯想集團至30.18%。平安好醫生漲超3%,同程藝龍漲超3%,美團反彈超3%,阿里巴巴漲超3%,明源雲漲超3%,舜宇漲近3%;騰訊小幅下跌0.25%,鴻騰精密大跌超4%,比亞迪電子大跌超5%。
藥品板塊集體衝高,截至10:15,信達生物漲超10%,業績顯示公司營收大增266.9%,研發開支增至18.52億元。京東健康漲超9%,2020年總收入顯著增長78.8%。康龍化成漲超9%,公司獲摩根士丹利增持40.9505萬股。石藥集團漲超5%,首創在研藥物JMT601獲美國臨牀試驗批準。聯邦製藥漲超4%,阿里健康漲超4%,復星醫藥漲超4%,上海醫藥漲超3%,麗珠醫藥、翰森醫藥均上漲超2%。
生物技術板塊拉昇,截至10:15,康方生物-B漲超9%,其開發藥品獲FDA授予突破性療法認定。君實生物漲超8%,麥格理上調君實生物目標價至92.62港元,評級“跑贏大市”。金斯瑞生物科技漲超6%,藥明巨諾-B漲超6%,藥明康德漲超6%,康希諾生物-B漲超5%,泰格醫藥漲超5%,錦欣生殖漲超5%,藥明生物漲超3%,百濟神州漲超2%。
影視娛樂板塊上揚,截至10:15,稻草熊娛樂漲超15%,稻草熊娛樂2020年度經調整後淨利潤增長100%,多項業績指標逆勢大漲。拉近網娛漲超10%,華夏視聽教育漲超6%,新石文化漲超4%,阿里影業、IMAX中國均漲超1%,貓眼娛樂、歡喜傳媒均漲不足1%。
體育用品板塊走強,截至10:15,安踏體育漲超5%,滔搏漲超2%,特步漲超1%,李寧漲近1%。
有色、鋼鐵板塊走弱,截至10:15,鞍鋼股份跌超2%,重慶鋼鐵股份跌超1%。江西銅業跌超3%,業績顯示2020年歸母淨利減少5.92%至23.2億元 末期股利每股0.1元。贛鋒鋰業跌超1%,紫金礦業、中國鋁業跌近1%。
汽車板塊受重挫,截至10:15,東風集團跌超6%,業績顯示公司年度收入同比增6.8%至1079.64億元。同樣績後的比亞迪,股價也下行,跌超4%,全年淨利潤及每股盈利不及預期。雅迪控股跌超3%,雅迪2020年營收同比增61.8%;淨利同比增89.6%。恆大汽車延續昨日跌勢,跌超2%。廣汽集團、吉利汽車均跌超1%,長城汽車逆市上漲超1%。
個股方面,中國奧園延續漲勢,漲超9%,全年歸母淨利增長41%至59.1億元。申洲國際漲超8%%,2020年純利達51.07億元,全年派息2港元;此前獲交銀國際上調評級。小米集團小幅上漲0.4%,公司昨日發佈小米11 Pro等多款新品,新品發佈會今晚還將繼續。
交易活躍的港股ETF方面,截至11:02,科技股ETF佔領榜單前五,XL二南方恆科(07226)大漲5.24%,成交額3892.88萬,換手率3.83%。華夏恆生生科(03068)緊隨其後,上漲4.95%,量比3.93。另一方面,做空類基金領跌,XI二南方恆科(07552)跌5.59%,成交額4203.84萬,換手率高達13.48%。FI二南方國指(07588)跌2.19%。
漲幅榜前五:

跌幅榜前五:

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.